TIDMIDEA

RNS Number : 7898J

Ideagen PLC

22 December 2015

Ideagen plc

("Ideagen" or the "Company")

Exercise of Options and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted 25,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of share options.

Application has been made to the London Stock Exchange for the 25,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 29 December 2015.

After Admission, the total number of Ordinary Shares in issue will be 178,883,428 and the total number of voting rights will therefore be 178,883,428. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 
 Enquiries: 
 Ideagen Plc                        Tel: 01629 699100 
 David Hornsby, Chief Executive 
 Graeme Spenceley, Finance 
  Director 
 
 finnCap (Nominated Adviser         Tel: 020 7220 0500 
  and Broker) 
 Stuart Andrews / James Thompso 
  (Corporate Finance) 
 Stephen Norcross (Corporate 
  Broking) 
 
 Alma PR 
 Hilary Buchanan                    Tel: 07780 901979 
 Josh Royston                       Tel: 07515 805218

About Ideagen plc

Ideagen is a UK company quoted on the AIM market of the London Stock Exchange (Ticker: IDEA.LN). Ideagen is a supplier of compliance based Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 1,500 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFLRFALLFIE

(END) Dow Jones Newswires

December 22, 2015 02:00 ET (07:00 GMT)

Ideagen (LSE:IDEA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ideagen Charts.
Ideagen (LSE:IDEA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ideagen Charts.